191 related articles for article (PubMed ID: 32582529)
41. Enhancing structural characterisation of glucuronidated O-linked glycans using negative mode ion trap higher energy collision-induced dissociation mass spectrometry.
Ashwood C; Abrahams JL; Nevalainen H; Packer NH
Rapid Commun Mass Spectrom; 2017 May; 31(10):851-858. PubMed ID: 28277614
[TBL] [Abstract][Full Text] [Related]
42. Involvement of CD40 targeting miR-224 and miR-486 on the progression of pancreatic ductal adenocarcinomas.
Mees ST; Mardin WA; Sielker S; Willscher E; Senninger N; Schleicher C; Colombo-Benkmann M; Haier J
Ann Surg Oncol; 2009 Aug; 16(8):2339-50. PubMed ID: 19475450
[TBL] [Abstract][Full Text] [Related]
43. Spectral library-based glycopeptide analysis-detection of circulating galectin-3 binding protein in pancreatic cancer.
Nigjeh EN; Chen R; Allen-Tamura Y; Brand RE; Brentnall TA; Pan S
Proteomics Clin Appl; 2017 Sep; 11(9-10):. PubMed ID: 28627758
[TBL] [Abstract][Full Text] [Related]
44. Lipid glycosylation: a primer for histochemists and cell biologists.
Kopitz J
Histochem Cell Biol; 2017 Feb; 147(2):175-198. PubMed ID: 27999995
[TBL] [Abstract][Full Text] [Related]
45. Quantitative analysis of total serum glycome in human and mouse.
Yoshida Y; Furukawa JI; Naito S; Higashino K; Numata Y; Shinohara Y
Proteomics; 2016 Nov; 16(21):2747-2758. PubMed ID: 27601404
[TBL] [Abstract][Full Text] [Related]
46. Engineering the protein N-glycosylation pathway in insect cells for production of biantennary, complex N-glycans.
Hollister J; Grabenhorst E; Nimtz M; Conradt H; Jarvis DL
Biochemistry; 2002 Dec; 41(50):15093-104. PubMed ID: 12475259
[TBL] [Abstract][Full Text] [Related]
47. O-glycans and O-glycosylation sites of recombinant human GM-CSF derived from suspension-cultured rice cells, and their structural role.
Kim J; Park H; Park BT; Hwang HS; Kim JI; Kim DK; Kim HH
Biochem Biophys Res Commun; 2016 Oct; 479(2):266-271. PubMed ID: 27638310
[TBL] [Abstract][Full Text] [Related]
48. Biomaterial substrate-derived compact cellular spheroids mimicking the behavior of pancreatic cancer and microenvironment.
Wong CW; Han HW; Tien YW; Hsu SH
Biomaterials; 2019 Aug; 213():119202. PubMed ID: 31132644
[TBL] [Abstract][Full Text] [Related]
49. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
[TBL] [Abstract][Full Text] [Related]
50. The O-linked glycosylation of secretory/shed MUC1 from an advanced breast cancer patient's serum.
Storr SJ; Royle L; Chapman CJ; Hamid UM; Robertson JF; Murray A; Dwek RA; Rudd PM
Glycobiology; 2008 Jun; 18(6):456-62. PubMed ID: 18332077
[TBL] [Abstract][Full Text] [Related]
51. Development of efficient on-bead protein elution process coupled to ultra-high performance liquid chromatography-tandem mass spectrometry to determine immunoglobulin G subclass and glycosylation for discovery of bio-signatures in pancreatic disease.
Shiao JY; Chang YT; Chang MC; Chen MX; Liu LW; Wang XY; Tsai YJ; Kuo TC; Tsai IL
J Chromatogr A; 2020 Jun; 1621():461039. PubMed ID: 32295703
[TBL] [Abstract][Full Text] [Related]
52. Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin.
Li CH; To KF; Tong JH; Xiao Z; Xia T; Lai PB; Chow SC; Zhu YX; Chan SL; Marquez VE; Chen Y
Gastroenterology; 2013 May; 144(5):1086-1097.e9. PubMed ID: 23395645
[TBL] [Abstract][Full Text] [Related]
53. Protein glycosylation in cancers and its potential therapeutic applications in neuroblastoma.
Ho WL; Hsu WM; Huang MC; Kadomatsu K; Nakagawara A
J Hematol Oncol; 2016 Sep; 9(1):100. PubMed ID: 27686492
[TBL] [Abstract][Full Text] [Related]
54. Changes in the profile of simple mucin-type O-glycans and polypeptide GalNAc-transferases in human testis and testicular neoplasms are associated with germ cell maturation and tumour differentiation.
Rajpert-De Meyts E; Poll SN; Goukasian I; Jeanneau C; Herlihy AS; Bennett EP; Skakkebaek NE; Clausen H; Giwercman A; Mandel U
Virchows Arch; 2007 Oct; 451(4):805-14. PubMed ID: 17694322
[TBL] [Abstract][Full Text] [Related]
55. O-glycosylation regulates LNCaP prostate cancer cell susceptibility to apoptosis induced by galectin-1.
Valenzuela HF; Pace KE; Cabrera PV; White R; Porvari K; Kaija H; Vihko P; Baum LG
Cancer Res; 2007 Jul; 67(13):6155-62. PubMed ID: 17616672
[TBL] [Abstract][Full Text] [Related]
56. Implications of altered O-glycosylation in tumour immune evasion.
Itano N
J Biochem; 2019 May; 165(5):387-390. PubMed ID: 30649348
[TBL] [Abstract][Full Text] [Related]
57. Quantitative O-glycomics based on improvement of the one-pot method for nonreductive O-glycan release and simultaneous stable isotope labeling with 1-(d
Wang C; Zhang P; Jin W; Li L; Qiang S; Zhang Y; Huang L; Wang Z
J Proteomics; 2017 Jan; 150():18-30. PubMed ID: 27585995
[TBL] [Abstract][Full Text] [Related]
58. Analysis of sialyl-Lewis x on MUC5AC and MUC1 mucins in pancreatic cancer tissues.
Balmaña M; Duran A; Gomes C; Llop E; López-Martos R; Ortiz MR; Barrabés S; Reis CA; Peracaula R
Int J Biol Macromol; 2018 Jun; 112():33-45. PubMed ID: 29408556
[TBL] [Abstract][Full Text] [Related]
59. Increased α1-3 fucosylation of α-1-acid glycoprotein (AGP) in pancreatic cancer.
Balmaña M; Giménez E; Puerta A; Llop E; Figueras J; Fort E; Sanz-Nebot V; de Bolós C; Rizzi A; Barrabés S; de Frutos M; Peracaula R
J Proteomics; 2016 Jan; 132():144-54. PubMed ID: 26563517
[TBL] [Abstract][Full Text] [Related]
60. Silencing ubiquitin-conjugating enzyme 2C inhibits proliferation and epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma.
Wang X; Yin L; Yang L; Zheng Y; Liu S; Yang J; Cui H; Wang H
FEBS J; 2019 Dec; 286(24):4889-4909. PubMed ID: 31715067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]